Bulk peptide is research-grade material sold in gram-scale rather than vial-scale quantities, priced per milligram against purity grade and synthesis difficulty. Comparing offers means normalizing to net peptide content per dollar and checking that each lot ships with a certificate of analysis covering identity, purity and the counterion.
- Bulk peptide is quoted on gross lyophilizate weight; net peptide content typically runs 60% to 90%, so offers only compare after normalization.
- Purity and peptide content are different measurements: a lot can honestly report 99% chromatographic purity and 70% gravimetric content at once.
- Per-milligram price falls with quantity because purification set-up and lot analytics are close to fixed costs per batch.
- Trifluoroacetate is the default counterion left by RP-HPLC purification; acetate exchange is an added processing step and is stated, never assumed.
- A lot-specific certificate with a visible chromatogram and mass spectrum is the minimum credible documentation for a gram-scale order.
What bulk means in this market
The word covers two different transactions, and a quote only makes sense once you know which one you are in. Catalog bulk is a supplier's standard compound in larger fill sizes: the same batch that fills 5 mg research vials, presented as 100 mg, 500 mg or a gram of lyophilizate. Custom bulk is a synthesis order: a sequence quoted per gram, made to schedule, with lead time in weeks and a minimum quantity the synthesis house will not go below.
The economics differ. Catalog bulk is priced off an existing batch, so the per-milligram figure falls quickly with fill size; the synthesis and purification were paid for when the batch was made, and the marginal cost of a larger fill is mostly the vial and the balance time. Custom bulk carries the entire batch cost alone, which is why a one-gram custom quote can land above the catalog price of the same nominal quantity pulled from stock.
One thing does not change between the two. The unit being sold is a gram of gross lyophilized solid, and gross solid includes bound water, the counterion left behind by purification, and any co-lyophilized salts. Every comparison in this guide runs on net peptide content for that reason. The arithmetic section below shows how far the difference moves the real price, and it is rarely a rounding error.
What actually sets the price
Synthetic peptide is built residue by residue on a solid support, cleaved, purified by preparative RP-HPLC, exchanged or not exchanged to a chosen salt form, lyophilized, and released against analytics. Each of those stages is visible in a quote if you know where to look.
| Driver | Effect on price | Why |
|---|---|---|
| Sequence length | Longer sequences cost more per milligram | Every residue is a coupling cycle, and crude purity falls as cycles accumulate |
| Difficult sequences | Sharp premiums for some stretches | Hydrophobic or aggregation-prone regions couple poorly and cost yield |
| Purity grade | Each step up costs disproportionately | Tighter cuts across the preparative peak discard more good material |
| Order quantity | Per-milligram price falls with scale | Purification set-up and lot analytics are close to fixed costs per batch |
| Counterion exchange | Acetate adds a step over TFA | Trifluoroacetate is what RP-HPLC purification leaves behind; exchange is extra processing |
| Depth of analytics | Small direct cost, large signal | Lot-specific mass spectrometry and HPLC cost real instrument time |
Purity grade is the driver buyers misread most often. Moving a specification from 95% to 98% does not mean the supplier worked three points harder; it means narrower fractions were kept from every preparative run, and the discarded shoulders were paid for all the same. Above 99% the yield loss compounds quickly. Whether an assay needs that grade is a protocol question, and it deserves an answer before the order goes in, because the premium is real and permanent.
Quantity pricing has a floor worth understanding. The discount curve flattens once the fixed costs of a batch are spread, so the difference between one gram and two is much smaller than the difference between 100 mg and a gram. A supplier quoting a per-milligram price at ten grams that sits barely below their one-gram rate is not being greedy; the chemistry simply stops getting cheaper.
Gross weight is not peptide content
A lyophilized cake is never pure peptide by mass. It carries bound water that survives freeze-drying, the counterion paired with every basic residue, and whatever salts came through the final step. Net peptide content, the fraction of gross mass that is actually the peptide, commonly runs between 60% and 90%, with the counterion and the sequence deciding where a given lot lands.
Content and purity are different numbers measured by different methods, and conflating them is the single most expensive confusion in peptide purchasing. Purity is chromatographic: of the peptide-related material present, what fraction is the target sequence. Content is gravimetric: of the powder on the balance, what fraction is peptide at all. A lot can honestly report 99% purity and 70% content at the same time. Content is established by amino acid analysis, nitrogen determination or UV absorbance where the sequence permits, and a certificate that names no method is reporting a guess.
The arithmetic settles comparisons that marketing cannot. Set two one-gram offers side by side:
Offer A: $900, content 70% → 1,000 mg × 0.70 = 700 mg net → $1.29 per mg
Offer B: $1,080, content 86% → 1,000 mg × 0.86 = 860 mg net → $1.26 per mg
The cheaper listing is not the cheaper material; here the higher sticker price wins by a small margin, and either way the gap between the gross figure and the true net figure is the largest correction in the whole comparison. The cost-per-milligram tool runs this normalization for any quote, and it is worth thirty seconds on every order above trivial size.
The documentation that should arrive with a lot
Research-grade material is not released under a pharmacopoeial monograph, so the certificate of analysis is doing all of the evidentiary work. The framework a competent certificate borrows is the one ICH and USP built for regulated peptide substances: identity, assay and impurities, each with a named method and a stated result for this specific lot.
| Document | What it establishes | Read it for |
|---|---|---|
| Mass spectrum | Identity | Observed mass against theoretical, on this lot, within instrument tolerance |
| RP-HPLC chromatogram | Purity as area percent | The actual trace with integration and method conditions, never a bare number |
| Peptide content statement | Real peptide mass per gross gram | The method named: amino acid analysis, nitrogen determination or UV |
| Counterion statement | Salt form of the lot | TFA unless exchange was performed and stated |
| Lot number | Chain of custody for all of the above | The same identifier on the vial, the certificate and any retest |
Two details separate a certificate that means something from one that decorates a listing. The first is the chromatogram itself. A purity percentage with no visible trace cannot be audited; the trace shows the shoulders, the void volume, and how the integration was drawn. The second is lot specificity. Certificates showing identical round numbers across every product and every batch are templates, and a template certifies nothing. The quality standard page documents what this catalog publishes per lot and why.
Evaluating a supplier before money moves
Most of the evaluation can be done from a desk, because the claims that matter are checkable in documents rather than in promises. Ask for the certificate of the actual lot on offer before paying, and read it against the table above. Ask whether the counterion is stated and whether content is reported separately from purity. Ask whether the material is in stock or queued for synthesis, and treat a vague answer as a lead time of weeks. None of these questions offends a competent operation; they are the questions its own quality-minded customers already ask.
Price itself is diagnostic once the cost structure is understood. Synthesis, purification, lyophilization and lot analytics set a floor, and an offer sitting far below every competitor is usually a sign of a skipped step rather than a bargain. The usual candidate is the analytics, which is why suspiciously cheap material so often arrives with a suspiciously thin certificate.
Red flags worth acting on: no lot number anywhere; purity above 99% claimed uniformly across an entire catalog; peptide content never mentioned; a certificate that cannot be produced until after payment; stock photography where a chromatogram should be. A dry rule of thumb holds up well here: how a supplier documents its cheapest item is a fair preview of how it documents its most expensive one.
Receipt, storage and the research boundary
Diligence continues at the receiving bench. Check the seal and closure before anything else, match the lot number on each vial against the certificate in hand, and record the arrival condition while the packaging is still in front of you. Dry solid tolerates transit far better than any solution, which is why bulk material ships lyophilized; the shipping page covers packaging and transit expectations, and the storage and stability guide covers what happens after the freezer door closes. Gram-scale lots reward one extra habit: subdivide into working portions early, so the master container is opened rarely and any condensation risk lands on small aliquots rather than on the whole purchase.
The boundary on all of it is the same one that governs every compound this catalog carries. FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
Common questions
What counts as bulk peptide?
Why do quotes for the same compound vary so widely?
What is the difference between purity and peptide content?
What should a certificate of analysis include for a bulk lot?
Is TFA or acetate the standard salt form?
Sources
- ICH quality guidelines on specifications and impurity control (Q6A and the Q3 family). The framework of identity, assay and impurity acceptance criteria that competent certificates of analysis borrow, described generically.
- USP compendial standards for peptide identity and purity testing. Establishes mass spectrometry for identity and RP-HPLC for purity as the reference methods a research certificate is read against.
- Peer literature on residual trifluoroacetate in synthetic peptides. Documents lot-to-lot variation in TFA counterion content and its influence on some in-vitro assay systems; cited generically because no single paper is load-bearing for the claim.